Copyright
©The Author(s) 2019.
World J Stem Cells. Jul 26, 2019; 11(7): 398-420
Published online Jul 26, 2019. doi: 10.4252/wjsc.v11.i7.398
Published online Jul 26, 2019. doi: 10.4252/wjsc.v11.i7.398
Figure 1 Targeting Wnt, hedgehog, notch, bone morphogenetic protein, B-cell-specific Moloney murine leukemia virus integration site, PI3K/Akt, and signal transducers and activators of transcription signaling pathways and the characteristics of cancer stem cells.
Bmi: B-cell-specific Moloney murine leukemia virus integration site; STAT: Signal transducers and activators of transcription; BMP: Bone morphogenetic protein.
- Citation: Du FY, Zhou QF, Sun WJ, Chen GL. Targeting cancer stem cells in drug discovery: Current state and future perspectives. World J Stem Cells 2019; 11(7): 398-420
- URL: https://www.wjgnet.com/1948-0210/full/v11/i7/398.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v11.i7.398